Universal Health Services (NYSE:UHS) Issues FY 2025 Earnings Guidance

Universal Health Services (NYSE:UHS) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 18.450-19.950 for the period, compared to the consensus EPS estimate of 18.160. The company issued revenue guidance of $17.0 billion-$17.4 billion, compared to the consensus revenue estimate of $16.7 billion.

Universal Health Services Stock Performance

Shares of Universal Health Services stock traded down $14.51 on Friday, reaching $171.55. The stock had a trading volume of 749,860 shares, compared to its average volume of 602,049. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. The business’s 50-day moving average price is $184.57 and its two-hundred day moving average price is $205.32. The stock has a market cap of $11.32 billion, a P/E ratio of 11.36, a price-to-earnings-growth ratio of 0.53 and a beta of 1.30. Universal Health Services has a fifty-two week low of $152.68 and a fifty-two week high of $243.25.

Universal Health Services (NYSE:UHS) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported $4.92 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.71. Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. The business had revenue of $4.11 billion during the quarter, compared to analysts’ expectations of $4.01 billion. On average, sell-side analysts forecast that Universal Health Services will post 15.92 EPS for the current year.

Universal Health Services Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be given a $0.20 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.80 annualized dividend and a dividend yield of 0.47%. Universal Health Services’s dividend payout ratio is 5.32%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on UHS. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $226.00 target price on shares of Universal Health Services in a research report on Tuesday, December 17th. The Goldman Sachs Group downgraded shares of Universal Health Services from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $228.00 to $198.00 in a report on Monday, December 16th. Stephens increased their target price on shares of Universal Health Services from $210.00 to $223.00 and gave the company an “equal weight” rating in a research note on Friday. Barclays decreased their target price on Universal Health Services from $271.00 to $249.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Cantor Fitzgerald raised Universal Health Services from a “neutral” rating to an “overweight” rating in a report on Monday, February 3rd. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Universal Health Services has an average rating of “Moderate Buy” and a consensus price target of $226.21.

Insider Transactions at Universal Health Services

In other news, Director Maria Ruderman Singer sold 1,614 shares of the business’s stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total value of $308,516.10. Following the transaction, the director now directly owns 5,879 shares of the company’s stock, valued at $1,123,770.85. The trade was a 21.54 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 16.10% of the stock is owned by insiders.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.